World's Best Scientists 2026 revealed!
Molecular Oncology
H-index 43

Molecular Oncology

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 529 394 502 33

Additional Metrics

Number of Best Scientists*: 946
Documents by Best Scientists*: 1055
Top 100 Ranked Scientists*: 27
SCIMAGO H-index: 121
SCIMAGO SJR: 1.957
Impact Factor: 4.5

Overview

Top Research Topics at Molecular Oncology?

The discussions in the journal mainly cover the fields of Cancer research, Cancer, Internal medicine, Oncology and Breast cancer. The Cancer research works featured in the journal incorporate elements from Cell growth, Cancer cell, Carcinogenesis, Downregulation and upregulation and Metastasis. The work tackled in Molecular Oncology goes beyond the discipline of Cancer cell as it also encompasses Cell biology.

It is focused mainly on Cell biology, particularly Signal transduction. Specifically, studies on Epithelial–mesenchymal transition are prevalent in the Metastasis works discussed. It explores topics in Cancer which can be helpful for research in disciplines like microRNA, Immunology and Bioinformatics.

Internal medicine research discussed connects with the study of Endocrinology. Many of the studies tackled connect Breast cancer with a similar field of study like Pathology.

  • Cancer research (53.98%)
  • Cancer (21.55%)
  • Internal medicine (16.07%)

What are the most cited papers published in the journal?

  • ITS primers with enhanced specificity for basidiomycetes--application to the identification of mycorrhizae and rusts. (1106 citations)
  • Deconstructing the molecular portraits of breast cancer. (929 citations)
  • MicroRNA and cancer. (792 citations)

Research areas of the most cited articles at Molecular Oncology:

The most cited publications facilitate discussions on Cancer research, Cancer, Internal medicine, Breast cancer and Pathology. While the most cited articles focused on Cancer research, they were also able to explore topics like Epithelial–mesenchymal transition, Metastasis, Cancer cell, Immunology and microRNA. The journal papers with studies in Cancer featured incorporate elements of Epigenetics and Bioinformatics.

What topics the last edition of the journal is best known for?

  • Gene
  • Cancer
  • Internal medicine

The previous edition focused in particular on these issues:

Molecular Oncology primarily tackles Cancer research, Cancer, Oncology, Internal medicine and Downregulation and upregulation. Molecular Oncology addresses concerns in Cancer research which are intertwined with other disciplines, such as Gene knockdown, Cancer cell, Carcinogenesis, Metastasis and Breast cancer. The journal holds forums on Cancer that merges themes from other disciplines such as Gene expression and Gene.

The presented research on Oncology deals specifically with Methylation but it also addresses topics in CpG site and Epigenetics. The featured Internal medicine research zeroes in on concepts in Clinical significance, Cohort and KRAS but also tackles themes under In patient. The concepts on Downregulation and upregulation presented in it can also apply to other research fields, including Tumor microenvironment, Tumor progression and Cell growth.

The most cited articles from the last journal are:

  • Physical activity, obesity and sedentary behavior in cancer etiology: epidemiologic evidence and biologic mechanisms (26 citations)
  • DNA in extracellular vesicles: biological and clinical aspects (14 citations)
  • Extracellular vesicles and oncogenic signaling. (11 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Molecular Oncology (based on the number of publications) are:

  • Anne Lise Børresen-Dale (31 papers) absent at the last edition,
  • Julio E. Celis (24 papers) published 1 paper at the last edition the same number as at the previous edition,
  • Ole Christian Lingjærde (16 papers) published 1 paper at the last edition,
  • John W.M. Martens (15 papers) published 2 papers at the last edition, 1 more than at the previous edition,
  • Janet Fricker (14 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Molecular Oncology (based on the number of publications) are:

  • University of Texas MD Anderson Cancer Center (59 papers) published 4 papers at the last edition, 1 more than at the previous edition,
  • Oslo University Hospital (58 papers) published 8 papers at the last edition, 5 more than at the previous edition,
  • University of Oslo (50 papers) published 5 papers at the last edition, 1 more than at the previous edition,
  • German Cancer Research Center (46 papers) published 11 papers at the last edition, 1 less than at the previous edition,
  • Karolinska Institutet (44 papers) published 4 papers at the last edition, 1 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 4.51% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 18.18% were posted by at least one author from the top 10 institutions publishing in the journal. Another 7.64% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 21.09% of all publications and 53.09% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Application of Molecular Oncology Research in Nursing Practice

The importance of Molecular Oncology in the field of medicine, particularly cancer research, cannot be overstated. However, translating this research into practical, patient-oriented healthcare is equally critical, particularly in the context of nursing. This link is often overlooked in many discussions.

Nurses, especially those specialized in oncology, have a vital role in applying the insights gained from Molecular Oncology research to provide personalized care for cancer patients. An understanding of the molecular basis of cancer can assist nurses in explaining the disease process to patients, helping them make informed decisions about treatment options, and managing potential side effects.

Additionally, nurses use this information to conduct risk assessment and genetic counselling, contribute in developing and delivering targeted therapies, monitor treatment response, and participate in patients' long-term follow-up care. The use of these research findings in oncology nursing can significantly influence patient outcomes.

For those interested in the intersection of oncology and nursing, understanding the path to becoming a nurse in this specialized field can be beneficial. For instance, you can find information here on how to be a nurse in west virginia

. Overall, bridging the gap between Molecular Oncology research and nursing practice will continue to improve cancer patient care, paving the way for a more integrated and personalized approach in managing this complicated disease.

Top Publications

  • Physical activity, obesity and sedentary behavior in cancer etiology: epidemiologic evidence and biologic mechanisms

    Christine M. Friedenreich;Christine M. Friedenreich;Charlotte Ryder‐Burbidge;Jessica McNeil

    (2021)
    383 Citations
  • LNCAROD is stabilized by m6A methylation and promotes cancer progression via forming a ternary complex with HSPA1A and YBX1 in head and neck squamous cell carcinoma

    Yuanyuan Ban;Yuanyuan Ban;Pingqing Tan;Jing Cai;Jing Cai;Junjun Li;Junjun Li

    (2020)
    164 Citations
  • Clinical utility of circulating tumor cells: an update

    (2020)
    153 Citations
  • miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastoma.

    Srinivas Chava;C. Patrick Reynolds;Anup S. Pathania;Santhi Gorantla

    (2020)
    132 Citations
  • Technology‐driven research for radiotherapy innovation

    (2020)
    125 Citations
  • Dual inhibition of TGF-β and PD-L1: a novel approach to cancer treatment.

    James L Gulley;Jeffrey Schlom;Mary Helen Barcellos-Hoff;Xiao-Jing Wang

    (2021)
    97 Citations
  • Image guidance in radiation therapy for better cure of cancer

    Vincent Grégoire;Matthias Guckenberger;Karin Haustermans;Jan J. W. Lagendijk

    (2020)
    95 Citations
  • A robust multiplex immunofluorescence and digital pathology workflow for the characterisation of the tumour immune microenvironment.

    Amélie Viratham Pulsawatdi;Stephanie G Craig;Victoria Bingham;Kris McCombe

    (2020)
    87 Citations
  • Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival.

    Lisa Quetel;Clément Meiller;Jean-Baptiste Assié;Yuna Blum

    (2020)
    79 Citations
  • Particle therapy in Europe.

    Cai Grau;Marco Durante;Dietmar Georg;Johannes A. Langendijk

    (2020)
    76 Citations

Related Online Degrees & Career Pathways

For those interested in pursuing a career in healthcare beyond medical school, a variety of online degree options are available. Nurses looking to advance their practice can explore msn to dnp online no clinicals programs, which offer flexibility by eliminating on-site clinical requirements.

Healthcare professionals aiming for leadership roles might consider the best online dha programs. These programs focus on healthcare management skills to prepare students for executive positions within hospitals and health systems.

Pharmacy is another promising pathway, with many universities offering online pharmacy schools designed to accommodate working professionals. These programs provide comprehensive training to become licensed pharmacists without relocating.

Additionally, individuals interested in the intersection of health and fitness can pursue a sports science degree online. This option equips students with knowledge of exercise physiology and rehabilitation to support athletic performance and wellness.

Best Scientists Contributing to This Journal

Recently Published Articles